Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G van den Dobbelsteen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical and Diagnostic Laboratory Immunology|May 9, 2000
Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific?A Soininen, G van den Dobbelsteen, L Oomen, et al.
Methods in Molecular Medicine|February 22, 2011
Serological characterizationB Kuipers, G van den Dobbelsteen, E Wedege, et al.
Archives of Virology|January 1, 1990
Detection of tomato spotted wilt virus using monoclonal antibodies and riboprobesC Huguenot, G van den Dobbelsteen, P de Haan, et al.
Vaccine|January 5, 2000
Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeysE Rouppe van der Voort, M Schuller, J Holst, et al.
Vaccine|November 9, 2004
Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-makingR Welte, G van den Dobbelsteen, J M Bos, et al.
Vaccine|October 24, 2001
Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccineE de Kleijn, L van Eijndhoven, C Vermont, et al.
Vaccine|April 25, 2000
In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A componentsK J Stittelaar, J Boes, G F Kersten, et al.
Vaccine|January 5, 2000
Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of ageE D de Kleijn, R de Groot, J Labadie, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical and Diagnostic Laboratory Immunology|May 9, 2000
Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific?A Soininen, G van den Dobbelsteen, L Oomen, et al.
Methods in Molecular Medicine|February 22, 2011
Serological characterizationB Kuipers, G van den Dobbelsteen, E Wedege, et al.
Archives of Virology|January 1, 1990
Detection of tomato spotted wilt virus using monoclonal antibodies and riboprobesC Huguenot, G van den Dobbelsteen, P de Haan, et al.
Vaccine|January 5, 2000
Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeysE Rouppe van der Voort, M Schuller, J Holst, et al.
Vaccine|November 9, 2004
Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-makingR Welte, G van den Dobbelsteen, J M Bos, et al.
Vaccine|October 24, 2001
Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccineE de Kleijn, L van Eijndhoven, C Vermont, et al.
Vaccine|April 25, 2000
In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A componentsK J Stittelaar, J Boes, G F Kersten, et al.
Vaccine|January 5, 2000
Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of ageE D de Kleijn, R de Groot, J Labadie, et al.
Pageof 1